Best peptides for injury recovery.
The most popular research peptide category, and the one where personal experience is least able to tell you whether anything worked.
Ranked by published evidence · reviewed June 1, 2026
Injury recovery peptides have a genuine scientific case and almost no clinical one. The mechanisms are real: several of these compounds promote angiogenesis, the growth of new blood vessels into damaged tissue, and others influence cell migration into a wound or modulate the inflammatory phase of repair. These are legitimate targets that pharmaceutical research also pursues.
What does not exist is controlled human evidence that taking them speeds recovery. The animal literature is deep, particularly for the best-known compound in the category, with rodent studies covering tendon, ligament, muscle and gut injury. The human trials are essentially absent. This is the single most important fact about the category and the one most consistently omitted from the pages selling these compounds.
Injury recovery is also uniquely bad terrain for judging by personal experience, which matters because that is what most people are relying on. Injuries heal on their own schedule. Someone using a healing peptide is almost always also resting, modifying training, and often doing physical therapy, each of which resolves injuries without help. Recovery after taking something cannot distinguish the compound from the recovery that was already underway, and pain and perceived function are strongly placebo-responsive.
The stacks deserve a specific note. The popular healing combinations are presented as synergistic, and no controlled study has tested any of them against placebo or against either component alone. Synergy in this category is an inference from two mechanisms existing, not a measurement of two mechanisms combining.
Strong mechanisms, deep animal literature, and no controlled human evidence that any of it translates. The category is not disproven, it is untested, and those are different claims that get conflated constantly here.
Ranked by evidence.
Ordered by PepCue's evidence tier, not by claimed effect size. A compound with a larger reported result but less human data ranks below one that has actually been tested.
- 01Pentosan PolysulfateB tier · 73/100FDA-approvedElmiron
Pentosan polysulfate sodium (PPS; brand name Elmiron) is a semisynthetic, sulfated polysaccharide derived from beechwood hemicellulose (xylan).
Full profile and sources → - 02GHK-CuD tier · 45/100Cosmetic / topicalcopper peptide
GHK-Cu is the copper(II) complex of GHK, a naturally occurring human tripeptide with the sequence glycyl-L-histidyl-L-lysine.
Full profile and sources → - 03Thymosin β-4D tier · 40/100Research / preclinical
Thymosin beta-4 (Tβ4) is a small, naturally occurring 43-amino-acid acidic peptide found in nearly all mammalian cells and in high concentrations in platelets, wound fluid, and many tissues.
Full profile and sources → - 04BPC-157D tier · 39/100Research / preclinicalbody protection compound
BPC-157 (sometimes written PL 14736 or "Body Protection Compound 157") is a synthetic pentadecapeptide, a chain of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, MW ~1419 Da).
Full profile and sources → - 05LL-37F tier · 34/100Research / preclinical
LL-37 is the only human cathelicidin-derived antimicrobial peptide, a 37-residue cationic, amphipathic alpha-helical peptide (named for its two leading leucine residues) cleaved from the C-terminus of the precursor protein hCAP18 (gene CAMP).
Full profile and sources → - 06TB-500F tier · 30/100Research / preclinicalthymosin β4 fragment
TB-500 is a synthetic peptide sold for research use and widely marketed as "thymosin beta-4 (Tβ4)." Naturally occurring Tβ4 is a 43-amino-acid, ~4.9 kDa actin-sequestering peptide found in nearly all mammalian cells and at high concentration in platelets and wound fluid.
Full profile and sources → - 07KPVF tier · 28/100Research / preclinical
KPV is a synthetic tripeptide composed of L-lysine, L-proline, and L-valine (Lys-Pro-Val), corresponding to the C-terminal residues 11-13 of alpha-melanocyte-stimulating hormone (alpha-MSH).
Full profile and sources → - 08B7-33F tier · 24/100Research / preclinicalsingle-chain relaxin analog
B7-33 is an experimental single-chain peptide derived from the B-chain of the human hormone relaxin-2 (H2 relaxin).
Full profile and sources →
FAQ.
Does BPC-157 heal tendons?
In rodents, the evidence for accelerated tendon and ligament healing is substantial and reproducible across multiple labs. In humans there are essentially no completed controlled trials, so whether that translates, at what exposure, and with what safety profile is unknown.
Is the BPC-157 and TB-500 stack better than either alone?
Nobody has tested it. There is no published study comparing the combination against either compound individually or against placebo, so any claim of synergy is reasoning from mechanism rather than a result.
Why does everyone say it worked for them?
Because injuries heal. Without a control group there is no way to separate a compound from rest, rehab, time and expectation, and subjective pain and function are among the most placebo-responsive outcomes measured in medicine.
Cite this page
PepCue. “Best peptides for injury recovery: the evidence, honestly assessed.” PepCue, reviewed June 1, 2026. https://www.pepcue.app/best-peptides-for/injury-recovery.